334-OR: Pemvidutide (ALT-801) , a Balanced (1:1) GLP-1/Glucagon Dual Receptor Agonist, Induces Rapid and Marked Weight Loss without the Need for Dose Titration in People with Overweight/Obesity
Year: 2022
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes
DOI: 10.2337/db22-334-or
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281699715
